Addiction Treatment Options: What to Expect

Most people who start researching addiction treatment feel overwhelmed within the first ten minutes. The terminology alone is enough to stop someone in their tracks: detox, MAT, PHP, IOP, dual diagnosis. Behind each of those abbreviations is a real approach that works for real people under the right circumstances. Understanding what those approaches actually involve, and how they connect to each other, makes the whole process far less intimidating.

This article breaks down the major categories of addiction treatment, explains what happens inside each one, and outlines the factors that typically guide clinical decisions about level of care. Whether someone is researching options for themselves or trying to help a family member, having an honest picture of the landscape is a good place to start.

Why One-Size Treatment Does Not Exist

Addiction affects people differently depending on the substance involved, how long the pattern has been going on, a person’s physical health, their mental health history, their living situation, and dozens of other variables. A 22-year-old dealing with a stimulant use disorder of eight months looks very different from a 50-year-old managing a 20-year alcohol use disorder alongside untreated depression. The treatment system is designed, at least ideally, to match the level and type of care to the actual needs of the individual rather than to a single protocol.

The American Society of Addiction Medicine developed a widely used placement criteria framework, often called ASAM criteria, that evaluates six dimensions of a person’s situation: withdrawal potential, biomedical conditions, emotional and behavioral conditions, readiness to change, relapse potential, and living environment. Clinicians use those dimensions to recommend an appropriate level of care, which may shift as a person progresses through treatment.

Medical Detoxification: The Starting Point for Many

For substances that cause physical dependence, such as alcohol, opioids, and benzodiazepines, abrupt discontinuation can produce withdrawal symptoms ranging from deeply uncomfortable to life-threatening. Medical detox is a supervised process, typically lasting two to ten days depending on the substance and the individual, during which clinicians monitor vital signs, manage symptoms with medications when appropriate, and keep the person safe as the substance clears from their system.

Detox is not treatment in the full sense. It addresses physical stabilization. Research consistently shows that people who complete detox without transitioning into further treatment have extremely high relapse rates, often within weeks. The value of detox lies in creating the biological conditions under which therapeutic work can begin, not in producing lasting change on its own.

Common Medications Used During Detox

• Benzodiazepines such as diazepam or lorazepam for alcohol withdrawal, to reduce seizure risk
• Buprenorphine or methadone to ease opioid withdrawal symptoms and cravings
• Clonidine to manage cardiovascular symptoms associated with opioid or stimulant withdrawal
• Anticonvulsants like carbamazepine, sometimes used as an alternative approach for alcohol withdrawal in certain clinical settings

Residential Treatment: Structured, Immersive Care

Residential treatment, sometimes called inpatient rehabilitation, provides around-the-clock care in a structured living environment. Programs typically run 28 to 90 days, though shorter and longer stays exist. The structure is intentional. Removing a person from their usual environment, the triggers, the social networks tied to use, the stress patterns, gives the brain and the therapeutic process room to work.

A typical day in residential treatment includes individual therapy, group therapy, psychoeducation, recreational or wellness activities, and sometimes family programming. Evidence-based modalities used in residential settings include cognitive behavioral therapy, dialectical behavior therapy, motivational interviewing, and contingency management. Many programs also integrate 12-step facilitation or similar peer-support frameworks.

Residential care is not appropriate for everyone, and it is not automatically more effective than outpatient care for every person. For people with severe dependence, minimal support at home, or significant co-occurring mental health conditions, it often provides a level of safety and structure that outpatient settings cannot replicate.

Outpatient Treatment: A Spectrum of Intensity

Outpatient treatment covers a wide range of service intensities, which is why it helps to understand the distinctions between the main levels. People sometimes assume outpatient means less serious treatment, but for many individuals, a well-structured outpatient program is the right clinical fit, especially when strong social support and a stable home environment are in place.

A person might enter treatment at a PHP level immediately after residential care, gradually step down to IOP over several weeks, and then continue with standard outpatient therapy for months or longer. This continuum model reflects research showing that longer engagement with treatment, even at lower intensity, improves long-term outcomes significantly.

For families or individuals trying to compare specific programs at different intensity levels, resources like siliconvalleyrecovery.com/treatment-options can offer a clearer picture of how those levels are structured within a particular clinical setting, which makes it easier to ask the right questions when evaluating providers.

Medication-Assisted Treatment and Its Role in Long-Term Recovery

Medication-assisted treatment, commonly abbreviated as MAT, combines FDA-approved medications with counseling and behavioral therapies to treat substance use disorders, most commonly opioid use disorder and alcohol use disorder. The term ‘assisted’ sometimes leads people to underestimate its significance, as if the medication is a crutch rather than a core therapeutic tool. The evidence does not support that view.

For opioid use disorder, the medications most supported by research are buprenorphine (available as Suboxone and other formulations), methadone administered through licensed opioid treatment programs, and naltrexone (available as Vivitrol in extended-release injectable form). According to the Substance Abuse and Mental Health Services Administration, people with opioid use disorder who receive MAT are significantly more likely to remain in treatment and less likely to experience overdose compared to those who receive no medication.

For alcohol use disorder, medications such as naltrexone, acamprosate, and disulfiram are FDA-approved options that work through different mechanisms to reduce cravings or create aversive reactions to alcohol. Despite solid evidence for their effectiveness, these medications remain vastly underused. A 2020 analysis published in JAMA Psychiatry found that fewer than 10 percent of people diagnosed with alcohol use disorder receive any FDA-approved medication for it.

Dual Diagnosis Treatment: Addressing Mental Health and Addiction Together

A significant proportion of people seeking addiction treatment also have a co-occurring psychiatric condition. Anxiety disorders, depression, PTSD, and bipolar disorder are among the most common. The relationship between mental health and substance use tends to be bidirectional: a person may use substances to manage psychological distress, which in turn worsens the underlying condition, which increases use. Treating only the addiction without addressing the mental health component leaves a major driver of relapse unaddressed.

Dual diagnosis programs, also called co-occurring disorder treatment or integrated treatment, are specifically designed to address both conditions simultaneously using a coordinated clinical team. This typically means psychiatrists or prescribers, licensed therapists with mental health and addiction training, and case managers working together rather than in separate silos. According to SAMHSA’s National Survey on Drug Use and Health, approximately 9.2 million adults in the United States experienced both a mental illness and a substance use disorder in 2018, yet only a fraction received treatment for both.

Questions to Ask When Evaluating Dual Diagnosis Programs

1. Does the program employ licensed psychiatrists or psychiatric nurse practitioners on staff, or does it refer out for mental health prescribing?
2. Are trauma-informed therapies such as EMDR or trauma-focused CBT available?
3. How does the program handle psychiatric medication management during and after treatment?
4. Is the mental health assessment completed before or at admission, not weeks into the program?
5. What is the staff-to-client ratio for individual therapy sessions?

Aftercare and Continuing Support

Completing a formal treatment program is a meaningful milestone. It is not the finish line. Research on addiction consistently shows that recovery is a long-term process, and the period immediately following treatment is when relapse risk tends to be highest. Aftercare refers to the structured support that follows primary treatment, and it takes many forms.

Sober living homes provide a substance-free living environment with peer accountability and typically require residents to maintain sobriety, contribute to household responsibilities, and engage in ongoing recovery activities. Ongoing outpatient therapy, continued MAT, alumni programs, peer support specialists, and participation in community-based mutual aid groups like Alcoholics Anonymous, SMART Recovery, or Refuge Recovery all serve as potential components of a durable aftercare plan.

The specific combination looks different for each person. Someone with a strong home environment and supportive family may need only weekly outpatient sessions and a peer support group. Someone with a more complicated social situation may benefit from a sober living residence for several months. Building a realistic, personalized aftercare plan before leaving primary treatment rather than improvising one afterward is one of the more practical things someone can do to protect the progress they have made.

Addiction treatment is not a single event. It is a sequence of clinical steps matched to a person’s evolving needs, supported by relationships, evidence-based therapies, and sometimes medication. The more clearly someone understands how those pieces fit together, the better positioned they are to ask the right questions, advocate for appropriate care, and build toward a recovery that actually holds.